Delivery Order SPE2DB22D2006-SPE2DB24FW1KV

Award Date 6/27/24
Potential Completion Date 6/28/24
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,964.60 firm fixed-price delivery order is for the supply of Lidocaine 5% patches, with a completion date of December 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of Lidocaine 5% Patch 30s medical supplies, with a total ceiling value of $45,047.39. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order type with a Firm Fixed Price pricing structure, and the ultimate completion date is June 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price valued at $1,138.89. The contract was awarded by the Defense Logistics Agency (DLA) and is for the supply of 4563680972 Lidocaine 5% Patch 30S, a medical product. The contract has an ultimate completion date of February 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,501.85 firm fixed-price delivery order is for the supply of Lidocaine 5% Patch 30s, a pharmaceutical product. The contract has an ultimate completion date of June 26, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,281.35 firm fixed-price delivery order is for the supply of Lidocaine 5% Patches, with a completion date of January 2, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a primary vehicle for the company to provide a comprehensive range of...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Lidocaine 5% Patch 30s. The contract, valued at $1,767.60, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract has an ultimate completion date of March 28, 2025 and was awarded on March 27, 2025. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,894.63 firm fixed-price delivery order covers the supply of Lidocaine 5% Patches, which are used for pain management. The contract has an ultimate completion date of November 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% Patches. The contract is a Delivery Order with a Firm Fixed Price type and a ceiling value of $2,339.48. The contract has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of 4558459998 Lidocaine 5% Patch 30s. The Firm Fixed Price delivery order, valued at $3,024.31, has a completion date of September 15, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,836.65 Firm Fixed Price Delivery Order is for the supply of Lidocaine 5% Patches. The contract has an ultimate completion date of October 28, 2024 and was awarded on October 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW1KV
    Delivery Order

This federal contract award is for the procurement of Lidocaine 5% Patch 30S by the Defense Logistics Agency (DLA) from Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $8,258.16 with a firm fixed price and an ultimate completion date of June 28, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed is a specific order placed against this larger DLA IDC mechanism. No set-aside designation was used for this contract.

Generated 5/17/25, 10:15 AM